Market Overview

XIFIN Unveils LIS 5 to Help Labs Improve Patient Outcomes, Optimize Operations and Support Precision Medicine Programs


Only lab information system that offers multi-specialty workflows,
universal image management and physician collaboration capabilities

. today announced the launch of XIFIN LIS 5 to help diagnostic
laboratories better integrate with the broader healthcare ecosystem to
improve patient outcomes and support precision medicine programs. The
latest evolution of its award-winning
laboratory information system (LIS), XIFIN LIS 5, is the only Software
as a Service (SaaS)-based, integrated and interoperable platform that
offers multi-specialty workflows—including molecular and
next-generation-sequencing (NGS) testing. Advanced capabilities also
include universal image management, digital pathology consultation, and
multidisciplinary care team collaboration.

This press release features multimedia. View the full release here:

Incomplete results can compromise patient safety. XIFIN LIS 5 comprehensive summary reports synthesi ...

Incomplete results can compromise patient safety. XIFIN LIS 5 comprehensive summary reports synthesize and display multi-specialty tests, graphical charts, diagnostic images, prior test results, and narrative and graphical interpretations in a single report. Summary reporting improves patient care and is an effective tool that drives loyalty and engagement with clients. XIFIN's laboratory information system can be further extended with the integrated universal image management and multi-disciplinary care team collaboration modules. Pathologists, radiologists, and oncologists can securely share diagnostic and genomic results, upload, view and annotate whole slide digital images, DICOM, and other medical images and to create a structured continuity of care document. (Graphic: Business Wire)

Integration between healthcare systems is more important than ever with
the rise of value-based care, making it crucial for laboratory
information to be included in this ecosystem. Historically, LIS
investments have been seen as costly necessities, when in reality they
are a source of revenue and important diagnostic decision-making
information. With increased interest in more complex diagnostic tests
such as molecular and NGS testing, the need for SaaS-based LIS platforms
is growing. According to a recent
survey1 on NGS trends in the clinical lab space
, 45
percent of respondents expect a significant increase in overall NGS
investment in sequencing instrumentation over the next two to three

offers highly configurable automation and dynamic reporting,
and includes updates to existing capabilities, such as its NGS module
that will now provide more specimen management, user-defined workflow
steps and the ability to support multiple lab processes. The platform's
enhanced clinical trials support system now provides a project-oriented
workflow for clients that perform clinical trials testing services.

"The XIFIN application is top notch and allows a lot of customization
options. It's one of the best I have used," said Robert Embree, EVP of
Operations at Pathnostics. "Furthermore, integrating XIFIN's LIS and RPM
revenue cycle management solutions has meant cleaner claims submitted
faster. It's improved our accounts receivables and has eliminated
keystroke and misinterpretation errors. We also now have a better
understanding of how a change in one system can impact the other system."

In addition to supporting multi-specialty workflows, XIFIN LIS 5 now
makes the following enhancements and advanced capabilities available:

  • Universal Image Management Module – Allows for the exchange of
    medical images securely and compliantly. It eliminates excess delays,
    costs and labor requirements by shifting from a manual process to an
    electronic workflow.
  • Multidisciplinary Care Team Collaboration Module – Breaks down
    communication silos so diagnostic service providers can consult and
    collaborate with colleagues inside and outside of their networks,
    across campuses and around the world, in real-time. Care teams can
    review multi-specialty patient diagnostic records, annotate whole
    slide digital images and create clinical summary documentation.
  • Digital Pathology Consultation Module – Improves quality
    assurance and minimizes risk by allowing providers to obtain digital
    pathology consults by conducting sub-specialty consultant profile
  • Enhanced Anatomic Pathology Module – Improves speed and
    functionality of new specialty workflows for gynecologic cytology,
    urology and GI. The gynecologic cytology module features an enhanced
    user interface and reporting capabilities, and the urology and GI
    modules more efficiently handle a large number of specimens and
    include administrative configuration screens.
  • Molecular Diagnostic and Genomics Workflows – Supports FISH,
    gene micro-array and PCR, as well as NGS and pharmacogenomics testing.

"The LIS market is highly fractured with many small single modality LIS
providers and custom development shops," said Lâle White, CEO, XIFIN.
"Interoperability and integration with the rest of the health system is
necessary to reduce costs through automation and efficiency, increase
revenue and improve patient outcomes. With XIFIN LIS 5, we're providing
our customers with a highly configurable solution that will allow their
LIS to grow and move with their organizations and better support
precision medicine programs."

SaaS-based information systems eradicate system silos and allow labs to
more easily integrate, communicate and exchange information with other
systems, as opposed to the siloed solutions labs build for themselves.
Plus, labs never have to worry about a single point of failure if, for
instance, the system expert suddenly is no longer available. For more
detail on the importance of investing in SaaS-based LIS systems,
download XIFIN's "The Build vs. Buy Conundrum of Laboratory Information
Systems" white paper at

For more information about XIFIN LIS 5 or to request a demo, visit

About XIFIN, Inc.

XIFIN is a healthcare information technology company that leverages
diagnostic information to improve the quality and economics of
healthcare. The company's cloud-based technology facilitates
connectivity and workflow automation for accessing and sharing clinical
and financial diagnostic data, linking healthcare stakeholders in the
delivery and reimbursement of care. To learn more, visit,
follow XIFIN on Twitter and LinkedIn,
or subscribe to the XIFIN

1 "William
Blair NGS Survey." The Dark Report, XIFIN, William Blair, August
2, 2018

View Comments and Join the Discussion!